Shahar Kol

The incidence and possible relevance of Y-linked microdeletions in babies born after intracytoplasmic sperm injection and their infertile fathers

Marijo Kent‐First, Shahar Kol, A. Muallem et al. · Molecular Human Reproduction · 1996 · 250 citations · Full text

Fertility, Genetics, Infertile Fathers +20

Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

Joseph Itskovitz‐Eldor, Shahar Kol, Bernadette Mannaerts · Human Reproduction · 2000 · 199 citations

Hormonal Contraceptive, Fertility, Reproductive Health +19

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol

Human M. Fatemi, Biljana Popovic-Todorovic, Peter Humaidan et al. · Fertility and Sterility · 2014 · 180 citations · Full text

Urology, Endocrine Mechanism, Gonadotropin Biology +9

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles

Shahar Kol, Abraham Lightman, Paul Devroey et al. · Human Reproduction · 1999 · 88 citations

In-vitro Fertilization Cycles, Hormonal Contraceptive, Fertility +19

The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process.

Shahar Kol, I Ben‐Shlomo, Kristiina Ruutiainen et al. · Journal of Clinical Investigation · 1997 · 74 citations · Full text

Fertility, Dependent Glucose Transporter, Glucose Transporter 3 +20